|Economy||Measure Code||Measure||Currency Code||Amount (Local)||Amount (USD)||Source||Post Date||Details|
|Bangladesh||04||04 - Equity support||BDT|
|Bangladesh||05||05 - Health and income support||BDT||427,695,000,000||5,034,667,451|
|Bangladesh||05A||05A - Health support||BDT||65,100,000,000||766,333,137||Ministry of Finance. https://mof.portal.gov.bd/sites/default/files/files/mof.portal.gov.bd/page/ed9e8b19_ccba_4cca_94b1_c40013f7a760/MTMPS_2020-21_English.pdf (accessed 29 June 6). Beximco Pharma. https://beximcopharma.com/beximco-news/latest-news/item/659-beximco-pharma-signs-mou-with-the-serum-institute-of-india-and-the-government-of-bangladesh-for-supply-of-a-covid-19-vaccine.html (accessed 06 Nov 2020). IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 15 January 2021).||
(i) BDT1 billion Special Honorarium for doctors, nurses, medical workers; (ii) BDT7.5 billion compensation in case infection/death; (iii) No amount/estimate: November 5, signs MOU with Beximco Pharma for the supply and distribution of 30 million doses of AstraZeneca vaccine; (iv) January 2021, BDT56.6 billion the government increased the COVID-19 Emergency Response and Pandemic Preparedness Project costs mostly reflecting the procurement, preservation and distribution of vaccines. [update]
|Bangladesh||05B||05B - Income support||BDT||362,595,000,000||4,268,334,314|
|Bangladesh||05B1||05B1 - Tax and contribution deferrals and policy changes||BDT|
|Bangladesh||05B2||05B2 - Tax and contribution rates reduction||BDT|
|Bangladesh||05B3||05B3 - Subsidies to individuals and households||BDT||78,170,000,000||920,188,346||Ministry of Finance. https://mof.portal.gov.bd/sites/default/files/files/mof.portal.gov.bd/page/ed9e8b19_ccba_4cca_94b1_c40013f7a760/MTMPS_2020-21_English.pdf (accessed 29 June 2020). Bangladesh Bank. https://www.bb.org.bd/mediaroom/circulars/fepd/may122020fepdl20.pdf (accessed 29 June 2020).||
(i) BDT12.58 billion Cash Transfer to targeted poor people; (ii)BDT8.15 billion expansion of cash allowance programs; (iii) BDT25.03 billion free food distribution; (iv) BDT2.51 billion OMS of rice at 10 taka/kg; (v) BDT21.3 billion construction of home for homeless people; (vii) BDT8.6 billion additional procurement of paddy/rice (2.0 lac ton); (vi) No amount/estimate: Expatriate Bangladeshis can get 2% incentives without showing any paper on remittance upto $5,000 (earlier $1,500) and for more than $5,000.
|Bangladesh||05B4||05B4 - Subsidies to businesses||BDT||189,425,000,000||2,229,841,083||Ministry of Finance. https://mof.portal.gov.bd/sites/default/files/files/mof.portal.gov.bd/page/ed9e8b19_ccba_4cca_94b1_c40013f7a760/MTMPS_2020-21_English.pdf (accessed 29 June 2020). Bangladesh Bank. https://www.bb.org.bd/mediaroom/circulars/fepd/may122020fepdl20.pdf (accessed 29 June 2020).||
(i) BTD20 billion, the Ministry of Finance will subsidize interest payments as mentioned in Measure 2 on working capital loans by scheduled banks to businesses; (ii) BDT2.0 billion Support for farm mechanization; (iii) BDT20 billion employment creation through four State owned entities; (iv) Export Development Fund has been increased by USD1.5 billion; (v) BDT20 billion subsidy for commercial bank's suspended interest of April-May, 2020;
|Bangladesh||05B5||05B5 - Indirect income support||BDT|
|Bangladesh||05B6||05B6 - No breakdown (income support)||BDT||95,000,000,000||1,118,304,885||Ministry of Finance. https://mof.portal.gov.bd/sites/default/files/files/mof.portal.gov.bd/page/ed9e8b19_ccba_4cca_94b1_c40013f7a760/MTMPS_2020-21_English.pdf (accessed 29 June 2020).||
(vi) BDT95 billion subsidy for agriculture.
|Bangladesh||05C||05C - No breakdown (health and income support)||BDT|
|Bhutan||04||04 - Equity support||BTN/INR|
|Bhutan||05||05 - Health and income support||BTN/INR||32,000,000,000||430,592,553|
|Bhutan||05A||05A - Health support||BTN/INR||2,000,000,000||26,912,035||IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 24 July 2020); Ministry of Health. https://www.gov.bt/covid19/?p=1658 (accessed 22 July 2020).||
(i) April 2020, An additional resource of BTN2 billion will be provided to the Ministry of Health to meet health-related spending; (ii) No amount/estimate: 20 July 2020, The government announced the exemption of COVID19 testing fees for the following categories of travellers: (a) undergraduate students and (b) referred patients and patient attendants approved by the referral committee.
|Bhutan||05B||05B - Income support||BTN/INR||30,000,000,000||403,680,518|
|Bhutan||05B1||05B1 - Tax and contribution deferrals and policy changes||BTN/INR||IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 24 July 2020); Official Statement from the Office of the Prime Minister of Bhutan (PMO). https://bit.ly/2yrZXYx (accessed 13 April 2020); PMO. https://bit.ly/3b6ygCh (accessed 6 May 2020); IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 24 July 2020); PMO. https://bit.ly/3efwMrR (accessed 18 June 2020); PMO. https://bit.ly/3ggtGo2 (accessed 1 July 2020); PMO. https://bit.ly/39oW0lW (accessed 20 July 2020).||
No amount/estimate: April 2020: (i) Business income tax (BIT) and corporate income tax (CIT) filing and tax payment for the income year 2019 will be deferred until 30 June 2020. 26 June 2020, targeted tax deferments will be provided over the next six to 12 months; (ii) Deferred payment of sales tax and customs duty on essential items (March–June 2020); (iii) Waiver of payment of rent and other charges (April–June 2020) by tourism-related business entities leasing government properties.
|Bhutan||05B2||05B2 - Tax and contribution rates reduction||BTN/INR||IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 24 July 2020); Official Statement from the Office of the Prime Minister of Bhutan (PMO). https://bit.ly/2yrZXYx (accessed 13 April 2020).||
No amount/estimate: 25 May 2020, The government will be refunding the 5% sales tax collected on telecom services collected on or after 16 January 2020.
|Bhutan||05B3||05B3 - Subsidies to individuals and households||BTN/INR|
|Bhutan||05B4||05B4 - Subsidies to businesses||BTN/INR||IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 24 July 2020); Official Statement from the Office of the Prime Minister of Bhutan (PMO). https://bit.ly/2yrZXYx (accessed 13 April 2020).||
No amount/estimate: 26 June 2020, rental waivers will be provided over the next six to 12 months.
|Bhutan||05B5||05B5 - Indirect income support||BTN/INR|
|Bhutan||05B6||05B6 - No breakdown (income support)||BTN/INR||30,000,000,000||403,680,518||Official Statement from the Office of the Prime Minister of Bhutan (PMO). https://bit.ly/2yrZXYx (accessed 13 April 2020); PMO. https://bit.ly/3b6ygCh (accessed 6 May 2020); IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 24 July 2020); PMO. https://bit.ly/3efwMrR (accessed 18 June 2020); PMO. https://bit.ly/3ggtGo2 (accessed 1 July 2020); PMO. https://bit.ly/39oW0lW (accessed 20 July 2020).||
April 2020, The National Resilience Fund has been approved and established. With a fund size amounting to about BTN30 billion, the resources will support the implementation of the following activities: (i) Grant of the Druk Gyalpo’s Relief Kidu to people who have been laid off or placed on reduced salaries to provide them immediate financial support. 30 April 2020, The Druk Gyalpo's Relief Kidu has granted BTN150 million as the first disbursement of the Relief Kidu to 13,006 people. On June 26, the government announced that the Druk Gyalpo Relief Kidu will continue from July to September 2020, however, with revision in amounts. The Relief Kidu has granted about BTN700 million between April and June 2020 to over 23,000 affected people ; (ii) Interest waiver (50% of cost) - effective May 1, the Royal Monetary Authority announced that the interest waiver would also be extended to non-performing loan accounts for a period of three months (April–June 2020). The government will finance 50% of the total interest payment and the financial institutions offered to support the other 50%. On 11 June 2020, The government handed over the e-fund payment to financial service providers for loan interest waiver for the month of April. The government is financing 50% of the interest waiver amounting to BTN625.96 million (Total amount of the interest waiver for April 2020 stands at BTN1.2 billion). 26 June 2020, The government announced to further extend interest waiver for another nine months for loans availed as of 10 April 2020. Full interest waiver will be granted from July to September 2020, followed by a partial interest waiver (50%) from October 2020 to March 2021. The cost of interest payment for the nine months is estimated at BTN7.5 billion and will be fully granted from the National Resilience Fund; (iii) Fast-track the implementation of the 12th Five Year Plan and wherever possible frontload the investments. 26 June 2020, In order to support front-loading of capital investments, procurement guidelines will be simplified including preferential treatment for local goods.
|Bhutan||05C||05C - No breakdown (health and income support)||BTN/INR|
|European Central Bank||04||04 - Equity support||EUR|
|European Central Bank||05||05 - Health and income support||EUR|
|European Central Bank||05A||05A - Health support||EUR|
|European Central Bank||05B||05B - Income support||EUR|
|European Central Bank||05B1||05B1 - Tax and contribution deferrals and policy changes||EUR|
|European Central Bank||05B2||05B2 - Tax and contribution rates reduction||EUR|
|European Central Bank||05B3||05B3 - Subsidies to individuals and households||EUR|
|European Central Bank||05B4||05B4 - Subsidies to businesses||EUR|
|European Central Bank||05B5||05B5 - Indirect income support||EUR|
|European Central Bank||05B6||05B6 - No breakdown (income support)||EUR|
|European Central Bank||05C||05C - No breakdown (health and income support)||EUR|
|European Union||04||04 - Equity support||EUR||549,000,000||607,300,885||EIB. https://www.eib.org/en/press/all/2020-103-eib-backs-eur5-billion-investment-to-mitigate-economic-impact-of-coronavirus-and-support-medical-technology (accessed 29 April 2020); Yale. https://som.yale.edu/faculty-research-centers/centers-initiatives/program-on-financial-stability/covid-19-crisis (accessed 29 April 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1007 (accessed 12 June 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1507 (accessed 27 August 2020).||
(i) 8 April 2020, The Commission is launching ESCALAR, a new investment approach, developed together with the European Investment Fund (EIF), that will support venture capital and growth financing for promising companies. In its pilot phase, ESCALAR will provide up to EUR300 million backed by the European Fund for Strategic Investments (EFSI); (ii) 24 April 2020, EIB also approved an equity investment worth EUR75 million for the German company Curevac, through the EIB's Infectious Disease Financing Facility; (iii) 8 June 2020, EUR174 million equity investments from the European Innovation Council (EIC) Accelerator Pilot funding to innovative startups and SMEs; (iv) June 2020, EUR5.3 billion for the Solvency Support Instrument that will work via an EU guarantee provided to the European Investment Bank (EIB) Group under the European Fund for Strategic Investments (EFSI). Solvency support will form a separate window under the EFSI to mobilise private capital. The EIB Group will use this guarantee to provide financing directly or invest, fund or guarantee equity funds, special purpose vehicles, investment platforms or national promotional banks. These intermediary funds or vehicles must be established and operate in the EU. The Solvency Support Instrument should predominantly channel solvency support through financial market intermediaries and only to a lesser degree facilitate direct support to companies by the EIB Group.
|European Union||05||05 - Health and income support||EUR||16,410,000,000||18,152,654,867|
|European Union||05A||05A - Health support||EUR||11,283,000,000||12,481,194,690||OECD. http://www.oecd.org/coronavirus/en/#country-tracker (accessed 15 April 2020); EC. https://www.consilium.europa.eu/en/press/press-releases/2020/09/11/addressing-covid-19-council-approves-6-2-billion-budget-increase-for-2020/ (accessed 12 September 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1671 (accessed 21 September 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1680 (accessed 21 September 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1416 (accessed 1 August 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1829 (accessed 10 October 2020); EIB. https://www.eib.org/en/press/all/2020-271-covid-19-eib-provides-eur50-million-to-navarre-to-strengthen-its-health-response-to-covid-19 (accessed 15 October 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_2041 (accessed 20 January 2021); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_2136 (accessed 21 November 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_2200 (accessed 28 November 2020); Council of the EU. https://www.consilium.europa.eu/en/press/press-releases/2020/12/07/council-greenlights-temporary-vat-relief-on-covid-19-vaccines-and-test-kits/ (accessed 7 December 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_21_50 (accessed 15 January 2021); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_21_51 (accessed 20 January 2021).||
(i) 13 March 2020, EUR800 million of the EU Solidarity Fund will be available by including a public health crisis within its scope, with a view of mobilizing it if needed for the hardest-hit EU member states; (ii) 19 March 2020, The European Commission (EC) decided to create a European civil protection stockpile of medical equipment (initial budget of EUR50 million, proposed to increase to EUR80 million) with a 90% Commission grant; (iii) 2 April 2020, The EC presented legislative proposals for an Emergency Support Instrument for the healthcare sector, (EUR3 billion) from the EU budget. 11 September 2020, The EC agreed to add EUR6.2 billion to the EU 2020 budget to address the impact of the COVID-19-crisis and to fund inter alia the vaccine strategy. The revised budget increases payments for the Emergency Support Instrument (ESI) by EUR1.09 billion to ensure the development and deployment of a COVID-19 vaccine. The Commission will use this money as a down-payment for pre-ordering vaccine doses. 18 September 2020, EU allocates EUR150 million for the transport of essential medical items through the ESI and entered into a contract with Sanofi-GSK to purchase up to 300 million doses of the Sanofi-GSK vaccine; (iv) EUR63 million, EC secures EU access to Remdesivir (first European treatment authorized for COVID-19); (v) No amount/estimate: 8 October 2020, the EC approved a third contract with a pharmaceutical company, Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Once the vaccine has proven to be safe and effective against COVID-19, the contract allows EU Member States to purchase vaccines for 200 million people. They will also have the possibility to purchase vaccines for an additional 200 million people; (vi) 13 October 2020, EIB is providing EUR50 million to the Autonomous Community of Navarre, Spain to strengthen its capacity to respond to the COVID-19 health crisis. The EU bank financing will enable the Spanish region to adapt its healthcare infrastructure to meet the additional costs generated by the pandemic; (vii) No amount/estimate: 11 November 2020, In order to step up the fight against the COVID-19 pandemic and future health emergencies, The EC is taking the first steps towards building the European Health Union. The Commission is putting forward a set of proposals to strengthen the EU's health security framework, and to reinforce the crisis preparedness and response role of key EU agencies [update]; (viii) No amount/estimate: 17 November 2020, The EC approves a fifth contract with CureVac for the initial purchase of 225 million doses of potential vaccine; (ix) No amount/estimate: 25 November 2020, The EC approved a sixth contract under the EU Vaccines Strategy, with the pharmaceutical company Moderna. The contract provides for the initial purchase of 80 million doses on behalf of all EU Member States; (x) 7 December 2020: The Council of Europe adopted amendments to the directive on the common system of value added tax (VAT) to allow member states to temporarily exempt COVID-19 vaccines and testing kits, as well as closely related services, from VAT; (xi) 11 January 2021, The EC supports blood services to increase COVID-19 convalescent plasma collection with grants amounting to EUR36 million financed through the ESI [update]; (xii) No amount/estimate: 12 January 2020, The EC concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19. The envisaged contract with Valneva would provide for the possibility for all EU Member States to purchase together 30 million doses, and they could further purchase up to 30 million more doses [update].
|European Union||05B||05B - Income support||EUR||327,000,000||361,725,664|
|European Union||05B1||05B1 - Tax and contribution deferrals and policy changes||EUR|
|European Union||05B2||05B2 - Tax and contribution rates reduction||EUR|
|European Union||05B3||05B3 - Subsidies to individuals and households||EUR||179,000,000||198,008,850||OECD. http://www.oecd.org/coronavirus/en/#country-tracker (accessed 15 April 2020).||
Mobilized European Globalisation Adjustment Fund to support dismissed workers and those self-employed (up to EUR179 million available in 2020).
|European Union||05B4||05B4 - Subsidies to businesses||EUR||148,000,000||163,716,814||OECD. http://www.oecd.org/coronavirus/en/#country-tracker (accessed 15 April 2020); IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 21 May 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1221 (accessed 9 July 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1872 (accessed 15 October 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1007 (accessed 12 June 2020).||
(i) No amount/estimate: 19 March 2020, EU Commission intends to allow State aid for struggling businesses and enable Member States to use the full flexibility foreseen under State aid rules. On 8 May 2020, the European Commission adopted a second amendment to extend the scope of the State aid Temporary Framework to recapitalization and subordinated debt measures to further support the economy in the context of the coronavirus outbreak. The amended Temporary Framework will be in place until the end of December 2020, except for recapitalization measures which has an extended period by the end of June 2021. The Commission will assess before these dates if they need to be extended. 29 June 2020, third amendment to the State aid extends Temporary Framework to enable Member States to provide public support under the Temporary Framework to all micro and small companies, even if they were already in financial difficulty on 31 December 2019; 13 October 2020, EC has decided to prolong and extend the scope of the State aid Temporary Framework adopted on 19 March 2020 to support the economy in the context of the coronavirus outbreak. All sections of the Temporary Framework are prolonged for six months until 30 June 2021, and the section to enable recapitalization support is prolonged for three months until 30 September 2021; (ii) 8 June 2020, European Innovation Council (EIC) Accelerator Pilot fund issued grants of EUR148 million to innovative companies.
|European Union||05B5||05B5 - Indirect income support||EUR|